Clin2
NCT07752069Possibly a fitNot yet recruiting

Testing different versions of an experimental medicine in healthy people

Lipoprotein Disorder

Part of Hormones & metabolism clinical trials.

This trial compares how well different forms of an experimental drug are absorbed by the body. Healthy volunteers will receive the drug and have blood tests to see which version works best.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
50 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be between 18 and 45 years old.
  • You must be in good general health (no serious medical conditions).
  • Your body mass index (BMI) must be between 19 and 28, and you must weigh at least 45 kg (99 lbs) if female or 50 kg (110 lbs) if male.
  • You must not have taken any prescription or over-the-counter medications within the last month.
  • You must be willing to use effective birth control during the trial and for 2 weeks after the last dose.
  • You must be a non-smoker (or smoke less than 5 cigarettes a day) and willing to avoid alcohol and caffeine during the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07767513Not yet recruiting· Phase 2
Oral medication for high lp(a) and heart risk

This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.

Chengdu, Sichuan
NCT07172646Recruiting· Phase 1/Phase 2
Testing SRSD216 for people with high lipoprotein (a)

This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.

Beijing, Beijing Municipality
NCT06867406Not yet recruiting· Phase 1
Safety study of a new tablet in healthy adults

This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.

Beijing, Beijing Municipality
NCT07551167Recruiting· Phase 1
Safety Study of HRS-5765 in Healthy Adults

This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.

Beijing, Beijing Municipality
NCT07229937Recruiting· Phase 2
Testing an experimental drug for high cholesterol

This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.

Harbin, Heilongjiang
NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu

Hear when a new Lipoprotein Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.